• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾周脂肪在患有或未患有糖尿病的慢性肾脏病个体肾功能不全中的作用:一项日本横断面研究。

Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study.

作者信息

Kono Teruyuki, Maimaituxun Gulinu, Tanabe Hayato, Higa Moritake, Saito Haruka, Tanaka Kenichi, Masuzaki Hiroaki, Sata Masataka, Kazama Junichiro J, Shimabukuro Michio

机构信息

Department of Diabetes, Endocrinology and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.

Department of Diabetes and Lifestyle-Related Disease Center, Tomishiro Central Hospital, Tomishiro, Okinawa, Japan.

出版信息

BMJ Open Diabetes Res Care. 2024 Mar 11;12(2):e003832. doi: 10.1136/bmjdrc-2023-003832.

DOI:10.1136/bmjdrc-2023-003832
PMID:38471672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10936520/
Abstract

INTRODUCTION

It remains unclear whether increased perirenal fat (PRF) accumulation is equally related to renal involvement in patients with and without diabetes mellitus (DM). We evaluated the association between PRF volume (PRFV) and low glomerular filtration rate (GFR) and proteinuria in people with or without type 2 diabetes mellitus (T2DM).

RESEARCH DESIGN AND METHODS

We performed a cross-sectional analysis of 473 individuals without T2DM (non-DM, n=202) and with T2DM (DM, n=271). PRFV (cm), obtained from non-contrast CT, was indexed as PRF index (PRFV/body surface area, cm/m). Multivariate-adjusted models were used to determine the ORs of PRFV and PRFV index for detecting estimated GFR (eGFR) decrease of <60 mL/min/1.73 m proteinuria onset, or both.

RESULTS

Although body mass index (BMI), visceral fat area, and waist circumference were comparable between the non-DM and DM groups, kidney volume, PRFV, and PRFV index were higher in individuals with T2DM than in those without T2DM. In the multivariate analysis, after adjusting for age, sex, BMI, hypertension, smoking history, and visceral fat area ≥100 cm, the cut-off values of PRFV index were associated with an eGFR<60 in individuals with DM (OR 6.01, 95% CI 2.20 to 16.4, p<0.001) but not in those without DM.

CONCLUSIONS

PRFV is associated with low eGFR in patients with T2DM but not in those without T2DM. This suggests that PRF accumulation is more closely related to the onset and progression of diabetic kidney disease (DKD) than non-DKD. Clarifying the mechanisms through which PRF influences DKD development could pave the way for novel prevention and treatment strategies.

摘要

引言

肾周脂肪(PRF)堆积增加与糖尿病(DM)患者和非糖尿病患者的肾脏受累之间是否同样相关仍不清楚。我们评估了2型糖尿病(T2DM)患者和非T2DM患者的PRF体积(PRFV)与低肾小球滤过率(GFR)及蛋白尿之间的关联。

研究设计与方法

我们对473名个体进行了横断面分析,其中无T2DM者(非DM,n = 202)和有T2DM者(DM,n = 271)。通过非增强CT获得的PRFV(cm)被标化为PRF指数(PRFV/体表面积,cm/m)。使用多变量调整模型来确定PRFV和PRF指数检测估计GFR(eGFR)降低至<60 mL/min/1.73 m²、蛋白尿发生或两者兼有的比值比(OR)。

结果

尽管非DM组和DM组之间的体重指数(BMI)、内脏脂肪面积和腰围相当,但T2DM患者的肾脏体积、PRFV和PRF指数高于非T2DM患者。在多变量分析中,在调整年龄、性别、BMI、高血压、吸烟史和内脏脂肪面积≥100 cm²后,PRF指数的临界值与DM患者的eGFR<60相关(OR 6.01,95%CI 2.20至16.4,p<0.001),但与非DM患者无关。

结论

PRFV与T2DM患者的低eGFR相关,但与非T2DM患者无关。这表明PRF堆积与糖尿病肾病(DKD)的发生和进展比与非DKD的关系更密切。阐明PRF影响DKD发展的机制可为新的预防和治疗策略铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8793/10936520/a0962e2035c0/bmjdrc-2023-003832f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8793/10936520/b65ff8f08ae4/bmjdrc-2023-003832f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8793/10936520/a0962e2035c0/bmjdrc-2023-003832f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8793/10936520/b65ff8f08ae4/bmjdrc-2023-003832f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8793/10936520/a0962e2035c0/bmjdrc-2023-003832f02.jpg

相似文献

1
Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study.肾周脂肪在患有或未患有糖尿病的慢性肾脏病个体肾功能不全中的作用:一项日本横断面研究。
BMJ Open Diabetes Res Care. 2024 Mar 11;12(2):e003832. doi: 10.1136/bmjdrc-2023-003832.
2
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
4
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
5
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
6
Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial.肾周脂肪作为代谢综合征的潜在标志物和治疗靶点:一项多中心随机对照试验的见解
Front Endocrinol (Lausanne). 2025 May 23;16:1557701. doi: 10.3389/fendo.2025.1557701. eCollection 2025.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers.使用先进生物标志物对2型糖尿病患者的糖尿病肾病进行评估和预测。
Nefrologia (Engl Ed). 2025 Jun-Jul;45(6):101330. doi: 10.1016/j.nefroe.2025.101330.
9
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
10
Novel Lipid Biomarkers and Microvascular Complications in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis.糖尿病患者的新型脂质生物标志物与微血管并发症:一项系统评价和荟萃分析
Clin Med Insights Endocrinol Diabetes. 2025 Aug 16;18:11795514251365301. doi: 10.1177/11795514251365301. eCollection 2025.

引用本文的文献

1
Analysis of HMGCS2 Expression and TG Lipidomics in the Perirenal Adipose Tissue of Obese Diabetic Nephropathy Mice.肥胖型糖尿病肾病小鼠肾周脂肪组织中HMGCS2表达及甘油三酯脂质组学分析
J Diabetes. 2025 Jul;17(7):e70125. doi: 10.1111/1753-0407.70125.

本文引用的文献

1
Management of traditional risk factors for the development and progression of chronic kidney disease.慢性肾脏病发生和进展的传统危险因素的管理。
Clin Kidney J. 2023 Apr 26;16(11):1737-1750. doi: 10.1093/ckj/sfad101. eCollection 2023 Nov.
2
The Fatty Kidney and Beyond: A Silent Epidemic.《肥胖相关性肾病及其它:一场无声的流行病》
Am J Med. 2023 Oct;136(10):965-974. doi: 10.1016/j.amjmed.2023.06.025. Epub 2023 Jul 13.
3
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
慢性肾脏病中的糖尿病管理:KDIGO 2022临床实践指南更新概要
Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10.
4
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023.11. 慢性肾脏病与风险管理:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S191-S202. doi: 10.2337/dc23-S011.
5
The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease.肾周脂肪在确定糖尿病肾病发病和进展风险中的作用
Int J Endocrinol. 2022 Nov 30;2022:2550744. doi: 10.1155/2022/2550744. eCollection 2022.
6
Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland.慢性肾病的发病率及风险因素:冰岛一项全国性研究的结果
Clin Kidney J. 2022 Feb 25;15(7):1290-1299. doi: 10.1093/ckj/sfac051. eCollection 2022 Jul.
7
Obesity-related glomerulopathy: Current approaches and future perspectives.肥胖相关性肾小球病:当前的方法和未来的展望。
Obes Rev. 2022 Jul;23(7):e13450. doi: 10.1111/obr.13450. Epub 2022 Apr 1.
8
Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imaging.脂肪性肾病:异位脂肪沉积的重要性及影像学的潜在价值
J Diabetes. 2022 Jan;14(1):73-78. doi: 10.1111/1753-0407.13232. Epub 2021 Oct 27.
9
Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes.肾周脂肪厚度与糖尿病患者慢性肾脏病发生风险显著相关。
Diabetes. 2021 Oct;70(10):2322-2332. doi: 10.2337/db20-1031. Epub 2021 Jun 22.
10
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective.基于聚类分析的成年发病型糖尿病分类的血糖控制和预防糖尿病并发症的新策略:一个视角。
Diabetes Res Clin Pract. 2021 Oct;180:109067. doi: 10.1016/j.diabres.2021.109067. Epub 2021 Sep 23.